发明名称 Vincamine analogues - for treating cardiovascular, cerebrovascular and respiratory insufficiency
摘要 <p>Vincamine analogues of formula (I) are new together with their acid-addn. salts as optically active forms or as racemates (where R1 is halo in 10 or 11 position, R2 is OH, R3 is H, or R2 and R3 together form a second bond). Daily adult dose is 3-600 mg depending on the disorder treated. The i.v. LD50 in mice is 47-52 mg/kg. similar to that of vincamine (47 mg/kg). A typical cpd. 10-chloro-16 DELTA-epi-14-vincamine, was prepd. by treating tabersonine in acid methanol with m-chloroperbenzoic acid.</p>
申请公布号 FR2423493(A1) 申请公布日期 1979.11.16
申请号 FR19770031526 申请日期 1977.10.19
申请人 OMNIUM CHIMIQUE SA 发明人
分类号 C07D461/00;(IPC1-7):07D471/22;61K31/47 主分类号 C07D461/00
代理机构 代理人
主权项
地址